Hépatique Oncologie interventionnelle Accès vasculaires / Cathéters

Hepatic arterial catheter/port for intra-arterial chemotherapy

Placement of a catheter or implantable port in the hepatic artery to deliver chemotherapy directly to the liver repeatedly.

3 doctors and centers ↓

The information below is provided for general educational purposes only. It describes the procedure in general terms and may not apply to your specific situation. Only your interventional radiologist can provide you with personalized information adapted to your case.

What does this intervention involve?

Background and indications

This device is offered for patients requiring prolonged hepatic intra-arterial chemotherapy, particularly for colorectal liver metastases or intrahepatic cholangiocarcinoma.

Benefits

Direct delivery into the hepatic artery allows much higher chemotherapy doses to the liver with fewer systemic side effects than intravenous chemotherapy.

Procedure

Under general anesthesia or deep sedation, a catheter is placed in the hepatic artery via the femoral route or in the operating room. Some digestive arteries may be preventively embolized to protect the stomach and duodenum. The catheter is connected to an implantable subcutaneous port.

Risks

Risks include catheter displacement, port infection, hepatic artery thrombosis or digestive ulcers if chemotherapy diffuses outside the liver.

Recovery and follow-up

2-3 day hospitalization. A control CT scan with catheter perfusion is performed before each chemotherapy cycle to verify proper positioning and absence of leaks.

Practical information

General anesthesia. Hospital stay: 2 to 3 nights.

This information does not replace a medical consultation. Each procedure is adapted to the patient's individual situation. Your doctor will explain the specific details, expected benefits and potential risks during your consultation.